Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice

Objective and Design: To investigate whether ivermectin, a semi-synthetic derivative of a family of macrocyclic lactones could inhibit lipopolysaccharide (LPS)-induced inflammation in vivo and in vitro.